Home Companies Catalysts Deep Dives

Dravet syndrome

DS · Neurology · 1 drugs · 1 indications

Competitive Landscape (1 drugs)
DrugCompanyMechanismModalityRouteStage
FinteplaUCBSerotonin receptor agonistSmall moleculeOralAPPROVED
Indications (1)
Dravet syndrome
Fintepla APPROVED
Upcoming Catalysts
Fintepla - Commercial UpdatesCOMMERCIAL
UCB2026
Data from Supabase · Updated 2026-03-24